FDA Airs Concerns About Hip Joints to Patients (MedPageToday)
In a set of web pages, the FDA cited problems that can arise from the inevitable release of metal particles as patients flex their new joints. Adverse reactions in the bones in which the implant is embedded also occur in some patients.
"Metal-on-metal hip replacement systems have unique risks in addition to the general. Among the warning signs of such systemic reactions, according to the FDA:
Chest pain
Shortness of breath
Neuropathies
Visual or hearing disturbance
Fatigue
Weight gain
Abnormal feelings of cold
Urinary trouble...
